k | d (P value) | β (P value) | 95% CI | I2, % | Q (P value) | |
---|---|---|---|---|---|---|
Comparison of stressful life events between patients with | 9 | 1.81 (0.01) | 0.43 to 3.19 | 98.0 | ||
GD and control groups | ||||||
Meta-regression of female gender on relation between | 9 | 0.22 (< 0.01) | 0.07 to 0.36 | |||
stressful life events and GD | ||||||
Meta-regression of mean age on relation between | 9 | −0.62 (< 0.01) | −0.80 to−0.43 | |||
stressful life events and GD | ||||||
Stratified analysis by NOS score | 0.58 (0.44) | |||||
Low-medium (6–7) | 5 | 1.30 (0.09) | −0.22 to 2.81 | 98.2 | ||
Medium-high (8–9) | 4 | 2.46 (0.02) | 0.12 to 5.04 | 99.0 | ||
Stratified analysis by Location | 0.04 (0.84) | |||||
Europe | 6 | 1.71 (0.01) | 0.16 to 3.58 | 98.4 | ||
Asia | 3 | 2.01 (0.09) | −0.28 to 4.30 | 98.9 | ||
Stratified analysis by different assessment for | 0.13 (0.72) | |||||
stressful life events | ||||||
Semi-structured interviews | 3 | 2.30 (0.23) | −1.49 to 6.09 | 99.2 | ||
Self-rating questionnaires | 6 | 1.57 (0.01) | 0.31 to 2.82 | 98.0 | ||
Comparison of stressful life events between not-cured | 4 | 0.32 (0.09) | −0.06 to 0.70 | 69.0 | ||
patients and cured patients with GD after druy therapy |